The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
Health Care Select Sector SPDR® ETF XLV
Morningstar’s Analysis XLV
Will XLV outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 55.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 11.60 | 4.6 Bil | Healthcare |
UnitedHealth Group Inc | 8.84 | 3.5 Bil | Healthcare |
Johnson & Johnson | 6.79 | 2.7 Bil | Healthcare |
Merck & Co Inc | 6.17 | 2.4 Bil | Healthcare |
AbbVie Inc | 5.34 | 2.1 Bil | Healthcare |
Thermo Fisher Scientific Inc | 4.28 | 1.7 Bil | Healthcare |
Abbott Laboratories | 3.35 | 1.3 Bil | Healthcare |
Danaher Corp | 3.20 | 1.3 Bil | Healthcare |
Amgen Inc | 3.15 | 1.2 Bil | Healthcare |
Pfizer Inc | 3.01 | 1.2 Bil | Healthcare |